Filter News
Area of Research
- Advanced Manufacturing (2)
- Biological Systems (2)
- Biology and Environment (60)
- Clean Energy (37)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (8)
- Fusion Energy (7)
- Isotopes (5)
- Materials (22)
- Materials for Computing (3)
- National Security (5)
- Neutron Science (17)
- Nuclear Science and Technology (14)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (1)
- Supercomputing (26)
News Topics
- (-) Advanced Reactors (34)
- (-) Bioenergy (91)
- (-) Biomedical (58)
- 3-D Printing/Advanced Manufacturing (120)
- Artificial Intelligence (91)
- Big Data (53)
- Biology (98)
- Biotechnology (22)
- Buildings (57)
- Chemical Sciences (63)
- Clean Water (29)
- Climate Change (99)
- Composites (26)
- Computer Science (187)
- Coronavirus (46)
- Critical Materials (25)
- Cybersecurity (35)
- Decarbonization (79)
- Education (4)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (108)
- Environment (194)
- Exascale Computing (37)
- Fossil Energy (5)
- Frontier (42)
- Fusion (54)
- Grid (62)
- High-Performance Computing (84)
- Hydropower (11)
- Irradiation (3)
- Isotopes (53)
- ITER (7)
- Machine Learning (47)
- Materials (143)
- Materials Science (139)
- Mathematics (7)
- Mercury (12)
- Microelectronics (3)
- Microscopy (51)
- Molten Salt (8)
- Nanotechnology (60)
- National Security (61)
- Net Zero (13)
- Neutron Science (131)
- Nuclear Energy (107)
- Partnerships (43)
- Physics (61)
- Polymers (33)
- Quantum Computing (34)
- Quantum Science (69)
- Renewable Energy (2)
- Security (24)
- Simulation (47)
- Software (1)
- Space Exploration (25)
- Statistics (3)
- Summit (57)
- Sustainable Energy (125)
- Transformational Challenge Reactor (7)
- Transportation (97)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
OAK RIDGE, Tenn., March 1, 2019—ReactWell, LLC, has licensed a novel waste-to-fuel technology from the Department of Energy’s Oak Ridge National Laboratory to improve energy conversion methods for cleaner, more efficient oil and gas, chemical and
While studying the genes in poplar trees that control callus formation, scientists at Oak Ridge National Laboratory have uncovered genetic networks at the root of tumor formation in several human cancers.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.
Scientists studying a valuable, but vulnerable, species of poplar have identified the genetic mechanism responsible for the species’ inability to resist a pervasive and deadly disease. Their finding, published in the Proceedings of the National Academy of Sciences, could lead to more successful hybrid poplar varieties for increased biofuels and forestry production and protect native trees against infection.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.